AMAL vs ZTS · P/E 9.8, rev $226.5M vs P/E 25, rev $2.47B
Amalgamated Bank (AMAL) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Amalgamated Bank (AMAL) is a banks - regional company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AMAL revenue for 2026-06-30 was $226.5M. Net income was $60.0M. AMAL currently screens at market cap $1.02B and trailing P/E 9.8.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
AMAL currently screens at market cap $1.02B and trailing P/E 9.8. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the AMAL and ZTS stock pages for the full models.
Not investment advice.